Valproate use in children and adolescents with bipolar disorder

CNS Drugs

Volumn 21, Issue 12, 2007, Pages 1019-1033

  Azorin, Jean Michel ^a   Findling, Robert L ^b,c  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescents; Antiepileptic drugs, general; Bipolar disorders; Children; Mood stabilisers, general; Valproic acid, general

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CLOZAPINE; HYDROCORTISONE; LITHIUM; LIVER ENZYME; MOOD STABILIZER; OLANZAPINE; OXCARBAZEPINE; PLACEBO; QUETIAPINE; RISPERIDONE; THYROID HORMONE; VALPROIC ACID; ZIPRASIDONE;

ABDOMINAL PAIN; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; BODY WEIGHT; CHILD PSYCHIATRY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMORBIDITY; COMPARATIVE STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCONVULSIVE THERAPY; GROUPS BY AGE; HAIR LOSS; HIGH RISK PATIENT; HUMAN; HYDROCORTISONE BLOOD LEVEL; INFERTILITY; MENTAL PATIENT; MONOTHERAPY; NAUSEA; OPEN STUDY; OVARY POLYCYSTIC DISEASE; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHIATRIC DIAGNOSIS; PSYCHIATRIC TREATMENT; RATING SCALE; RETROSPECTIVE STUDY; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; SYMPTOM; TERATOGENICITY; THYROID HORMONE BLOOD LEVEL; TREATMENT DURATION; TREMOR; VOMITING; WEIGHT GAIN; YOUNG MANIA RATING SCALE;

ADOLESCENT; ANTIMANIC AGENTS; BIPOLAR DISORDER; CHILD; CHILD, PRESCHOOL; HUMANS; PEDIATRICS; VALPROIC ACID;

EID: 36248930380     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200721120-00005     Document Type: Review

References (58)

1. Kyte ZA, Carlson GA, Goodyer IM. Clinical and neuropsychological characteristics of child and adolescent bipolar disorder. Psychol Med 2006 Sep; 36 (9): 1197-211
2. Geller B, Luby J. Child and adolescent bipolar disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1997 Sep; 36 (9): 1168-76
3. Lewinsohn PM, Klein DN, Seeley JR. Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry 1995 Apr; 34 (4): 454-63
4. Soutullo CA, Chang KD, Diez-Suarez A, et al. Bipolar disorder in children and adolescents: international perspective on epidemiology and phenomenology. Bipolar Disord 2005 Dec; 7 (6): 497-506
5. Citrome L, Goldberg JF. Commentary: bipolar disorder is a potentially fatal disease. Postgrad Med 2005; 117 (2): 9-11
6. Sasson Y, Chopra M, Harrari E, et al. Bipolar comorbidity: from diagnostic dilemmas to therapeutic challenge. Int J Neuropsychopharmacol 2003; 6 (2): 139-44
7. Goldstein TR, Birmaher B, Axelson D, et al. History of suicide attempts in pediatric bipolar disorder: factors associated with increased risk. Bipolar Disord 2005 Dec; 7 (6): 525-35
8. Geller B, Bolhofner K, Craney JL, et al. Psychosocial functioning in a prepubertal and early adolescent bipolar disorder phenotype. J Am Acad Child Adolesc Psychiatry 2000; 39 (12): 1543-8
9. Carter TD, Mundo E, Parikh SV, et al. Early age at onset as a risk factor for poor outcome of bipolar disorder. J Psychiatr Res 2003 Jul-Aug; 37 (4): 297-303
10. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition. Washington, DC: American Psychiatric Association, 1994
11. Kowatch RA, Fristad M, Birmaher B, et al. Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2005 Mar; 44 (3): 213-35
12. McClellan J. Commentary: treatment guidelines for child and adolescent bipolar disorder. J Am Acad Child Adolesc Psychiatry 2005 Mar; 44 (3): 236-9
13. National Institute of Mental Health. Child and adolescent bipolar disorder: an update from the National Institute of Mental Health 2000 [online]. Available from URL: http://www.nimh.nih.gov/publicat/NIMHbipolarupdate.pdf [Accessed 2007 Apr 24]
14. Birmaher B, Brent DA, et al. Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder. Arch Gen Psychiatry 2000 Jan; 57 (1): 29-36
15. Mufson L, Weissman MM, Moreau D, et al. Efficacy of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry 1999 Jun; 56 (6): 573-9
16. Keck Jr PE, McElroy SL. Divalproex in the treatment of bipolar disorder. Psychopharmacol Bull 2003; 37 Suppl. 2: 67-73
17. Bowden CL. Spectrum of effectiveness of valproate in neuropsychiatry. Expert Rev Neurother 2007 Jan; 7 (1): 9-16
18. Tohen M, Kryzhanovskaya L, Carlson G, et al. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am J Psychiatry 2007 Oct; 164 (10): 1547-56
19. US Food and Drug Administration. FDA approves Risperdal for two psychiatric conditions in children and adolescents, August 22, 2007 [online]. Available from URL: http://www.fda.gov/bbs/topics/NEWS/2007/NEW01686.html [Accessed 2007 Oct 9]
20. Dutta S, Zhang Y, Conway JM, et al. Divalproex-ER pharmacokinetics in older children and adolescents. Pediatr Neurol 2004 May; 30 (5): 330-7
21. Thakur A, Dutta S, Sinha VK. Intravenous valproate in acute adolescent mania: a preliminary report. Eur Child Adolesc Psychiatry 2004 Aug; 13 (4): 258-61
22. DelBello MP, Schwiers ML, Rosenberg HL, et al. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 2002 Oct; 41 (10): 1216-23
23. Findling RL, McNamara NK, Youngstrom EA, et al. Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 2005 May; 44 (5): 409-17
24. Findling RL, McNamara NK, Gracious BL, et al. Combination lithium and divalproex sodium in pediatric bipolarity. J Am Acad Child Adolesc Psychiatry 2003 Aug; 42 (8): 895-901
25. DelBello MP, Kowatch RA, Adler CM, et al. A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolesc Psychiatry 2006 Mar; 45 (3): 305-13
26. Segal S. A double-blind, placebo-controlled trial to evaluate the safety and efficacy of depakote ER for the treatment of mania associated with bipolar disorder in children and adolescents [online]. Available from URL: http://www.clinicalstudyresults.org/drugdetails/?.company_id=1&sort=c. company_name&page=1&drug_id=1561 [Accessed 2007 Jun 22]
27. Findling RL, Frazier TW, Youngstrom EA, et al. Double-blind, placebo-controlled trial of divalproex monotherapy in the treatment of symptomatic youth at high risk for developing bipolar disorder. J Clin Psychiatry 2007 May; 68 (5): 781-8
28. Kowatch RA, Suppes T, Carmody TJ, et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2000 Jun; 39 (6): 713-20
29. Papatheodorou G, Kutcher SP, Katic M, et al. The efficacy and safety of divalproex sodium in the treatment of acute mania in adolescents and young adults: an open clinical trial. J Clin Psychopharmacol 1995 Apr; 15 (2): 110-6
30. Deltito JA, Levitan J, Damore J, et al. Naturalistic experience with the use of divalproex sodium on an in-patient unit for adolescent psychiatric patients. Acta Psychiatr Scand 1998 Mar; 97 (3): 236-40
31. Wagner KD, Weller EB, Carlson GA, et al. An open-label trial of divalproex in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2002 Oct; 41 (10): 1224-30
32. Chang KD, Dienes K, Blasey C, et al. Divalproex monotherapy in the treatment of bipolar offspring with mood and behavioral disorders and at least mild affective symptoms. J Clin Psychiatry 2003 Aug; 64 (8): 936-42
33. Kowatch RA, Sethuraman G, Hume JH, et al. Combination pharmacotherapy in children and adolescents with bipolar disorder. Biol Psychiatry 2003 Jun 1; 53 (11): 978-84
34. Pavuluri MN, Henry DB, Carbray JA, et al. Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania. J Affect Disord 2004 Oct; 82 Suppl. 1: S103-11
35. Pavuluri MN, Henry DB, Carbray JA, et al. Divalproex sodium for pediatric mixed mania: a 6-month prospective trial. Bipolar Disord 2005 Jun; 7 (3): 266-73
36. Scheffer RE, Kowatch RA, Carmody T, et al. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry 2005 Jan; 162 (1): 58-64
37. Findling RL, McNamara NK, Stansbrey R, et al. Combination lithium and divalproex sodium in pediatric bipolar symptom re-stabilization. J Am Acad Child Adolesc Psychiatry 2006 Feb; 45 (2): 142-8
38. Henry CA, Zamvil LS, Lam C, et al. Long-term outcome with divalproex in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 2003; 13 (4): 523-9
39. DelBello MP, Adler C, Strakowski SM. Divalproex for the treatment of aggression associated with adolescent mania. J Child Adolesc Psychopharmacol 2004; 14 (2): 325-8
40. State RC, Frye MA, Altshuler LL, et al. Chart review of the impact of attention-deficit/hyperactivity disorder comorbidity on response to lithium or divalproex sodium in adolescent mania. J Clin Psychiatry 2004 Aug; 65 (8): 1057-63
41. Barzman DH, DelBello MP, Adler CM, et al. The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s). J Child Adolesc Psychopharmacol 2006 Dec; 16 (6): 665-70
42. Saxena K, Howe M, Simeonova D, et al. Divalproex sodium reduces overall aggression in youth at high risk for bipolar disorder. J Child Adolesc Psychopharmacol 2006 Jun; 16 (3): 252-9
43. Rademacher J, DelBello MP, Adler C, et al. Health-related quality of life in adolescents with bipolar I disorder. J Child Adolesc Psychopharmacol 2007 Feb; 17 (1): 97-103
44. Bowden CL. Making use of combination pharmacotherapy in bipolar disorder. J Clin Psychiatry 2004; 65 Suppl. 15: 21-4
45. Tohen M, Chengappa KN, Suppes T, et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 2002 Jan; 59 (1): 62-9
46. Papatheodorou G, Kutcher SP. Divalproex sodium treatment in late adolescent and young adult acute mania. Psychopharmacol Bull 1993; 29 (2): 213-9
47. Chengappa KN, Baker RW, Shao L, et al. Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania. Bipolar Disord 2003 Feb; 5 (1): 1-5
48. Cookson J, Keck Jr PE, Ketter TA, et al. Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study. Int Clin Psychopharmacol 2007 Mar; 22 (2): 93-100
49. Gopal S, Steffens DC, Kramer ML, et al. Symptomatic remission in patients with bipolar mania: results from a double-blind, placebo-controlled trial of risperidone monotherapy. J Clin Psychiatry 2005 Aug; 66 (8): 1016-20
50. Jairam R, Srinath S, Girimaji SC, et al. A prospective 4-5 year follow-up of juvenile onset bipolar disorder. Bipolar Disord 2004 Oct; 6 (5): 386-94
51. Correll CU. Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials. J Am Acad Child Adolesc Psychiatry 2007 Jun; 46 (6): 687-700
52. Genton P, Semah F, Trinka E. Valproic acid in epilepsy: pregnancy-related issues. Drug Saf 2006; 29 (1): 1-21
53. Joffe H. Reproductive biology and psychotropic treatments in premenopausal women with bipolar disorder. J Clin Psychiatry 2007; 68 Suppl. 9: 10-5
54. Genton P, Bauer J, Duncan S, et al. On the association between valproate and polycystic ovary syndrome. Epilepsia 2001 Mar; 42 (3): 295-304
55. Nishimura T, Sakai M, Yonezawa H. Effects of valproic acid on fertility and reproductive organs in male rats. J Toxicol Sci 2000 May; 25 (2): 85-93
56. Cohn DF, Homonnai ZT, Paz GF. The effect of anticonvulsant drugs on the development of male rats and their fertility. J Neurol Neurosug Psychiatry 1982 Sep; 45 (9): 844-6
57. Isojarvi JI, Lofgren E, Juntunen KS, et al. Effect of epilepsy and antiepileptic drugs on male reproductive health. Neurology 2004 Jan 27; 62 (2): 247-53
58. Guerrini R. Valproate as a mainstay of therapy for pediatric epilepsy. Paediatr Drugs 2006; 8 (2): 113-29